Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Stage II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of HSK21542 Tablets for the Treatment of Moderate-to-severe Pruritus in Peritoneal Dialysis Subjects

NCT06290375 is registered in ClinicalTrials.gov with Xizang Haisco Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT06290375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06290375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Stage II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of HSK21542 Tablets for the Treatment of Moderate-to-severe Pruritus in Peritoneal Dialysis Subjects
Lead sponsor
Xizang Haisco Pharmaceutical Co., Ltd
Phase
Phase 2
Overall status
Unknown status
Start date
March 8, 2024
Completion date
April 11, 2025
Enrollment
250 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pruritus